RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

82 hedge funds and large institutions have $391M invested in Revance Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 15 closing their positions.

Holders
82
Holders Change
-4
Holders Change %
-4.65%
% of All Funds
2.19%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
11
Increased
34
Reduced
18
Closed
15
Calls
$855K
Puts
$268K
Net Calls
+$587K
Net Calls Change
+$474K
Name Market Value Shares Shares
Change
Shares
Change %
UBS Group
76
UBS Group
Switzerland
$7K 511
Zurich Cantonal Bank
77
Zurich Cantonal Bank
Switzerland
$5K 380
WAS
78
Winch Advisory Services
Wisconsin
$3K 200
TRCT
79
Tower Research Capital (TRC)
New York
$2K 191 -647 -77%
AG
80
Advisor Group
Arizona
$1K 100 +100 New
DCM
81
Driehaus Capital Management
Illinois
-117,168 Closed
JCG
82
JHL Capital Group
Illinois
-110,000 Closed
Lord, Abbett & Co
83
Lord, Abbett & Co
New Jersey
-94,700 Closed
Millennium Management
84
Millennium Management
New York
-93,115 Closed
FAM
85
Fred Alger Management
New York
-84,288 Closed
Invesco
86
Invesco
Georgia
-69,594 Closed
CCI
87
Columbus Circle Investors
-63,398 Closed
D.E. Shaw & Co
88
D.E. Shaw & Co
New York
-54,621 Closed
TI
89
Trexquant Investment
Connecticut
-48,002 Closed
Susquehanna International Group
90
Susquehanna International Group
Pennsylvania
-39,781 Closed
Ameriprise
91
Ameriprise
Minnesota
-13,815 Closed
DekaBank Deutsche Girozentrale
92
DekaBank Deutsche Girozentrale
Germany
-13,600 Closed
Citadel Advisors
93
Citadel Advisors
Florida
-12,178 Closed
SG Americas Securities
94
SG Americas Securities
New York
-7,351 Closed
PAM
95
Paradigm Asset Management
New York
-3,000 Closed
SM
96
Sabby Management
Florida
HR
97
Howe & Rusling
New York
$0 21
LTFS
98
Ladenburg Thalmann Financial Services
Florida
$0 12 +12 New